OmniaBio Inc., a next generation contract development and manufacturing organization (CDMO) pioneering the manufacturing of ...
The deubiquitinase USP17LA negatively regulates T-cell activation and attenuates anti-tumor immunity
USP17LA loss enhances T-cell function and anti-tumor activity in murine tumor models. Usp17la-deficient T cells exhibit ...
Takeda Pharmaceutical said on Wednesday it will stop its cell therapy initiatives and seek a partner to advance its research ...
T cell development is a tightly regulated process that transforms immature thymocytes into mature T cells with distinct functionalities. In the thymus, precursor cells undergo a series of selection ...
SciTech Development Inc., a clinical-stage oncology company in Detroit, has closed its Convertible Note Round No. 3 (CNR 3) ...
HPV, a very common virus, is found to hijack the body's cells to directly drive skin cancer growth, even after surgeries and ...
SciTech Development, Inc., a clinical-stage oncology company advancing its innovative nanotechnology-enabled cancer drug, ...
Invariant natural killer T (iNKT) cells represent a unique lymphocyte subset that bridges innate and adaptive immunity. Their development originates in the thymus from double‐positive precursor cells, ...
UCSF researchers designed a CAR T-cell therapy and combined it with an older class of diabetes drugs called ...
The Notch signaling pathway plays a pivotal role in determining cell fate, especially in the development and function of T cells. But mimicking this highly mechanical, contact-dependent pathway in the ...
X™ T-Cell Transduction Sponge is honored in the Lab Research Tools category of the 2025 Top Innovations contest.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback